國立虎尾科技大學 |

Anticancer Plants: Natural Products and Biotechnological Implements = Volume 2 /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Anticancer Plants: Natural Products and Biotechnological Implements/ edited by Mohd Sayeed Akhtar, Mallappa Kumara Swamy.
Reminder of title:	Volume 2 /
other author:	Akhtar, Mohd Sayeed.
Description:	XV, 564 p. 139 illus., 21 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Plant physiology. -
Online resource:	https://doi.org/10.1007/978-981-10-8064-7
ISBN:	9789811080647

Anticancer Plants: Natural Products and Biotechnological Implements = Volume 2 /
Anticancer Plants: Natural Products and Biotechnological ImplementsVolume 2 /[electronic resource] :edited by Mohd Sayeed Akhtar, Mallappa Kumara Swamy. - 1st ed. 2018. - XV, 564 p. 139 illus., 21 illus. in color.online resource.

Chapter 1. Fungal Endophytes as Novel Sources of Anticancer Compounds -- Chapter 2. Gastrointestinal Bezoar Stones: Current Knowledge and Future Pperspective on the Potential of Plant-derived Phytobezoar in Cancer Treatment -- Chapter 3. Potential of Natural Products for Prevention of Oral Cancer -- Chapter 4. Therapeutic Potential of Cardiac Glycosides Against Cancer -- Chapter 5. Conserving Biodiversity of a Potent Anticancer Plant, Catharanthus roseus Through In vitro Biotechnological Intercessions: Substantial Progress and Imminent Prospects -- Chapter 6. Medicinal Plants as a Potential Source of Chemopreventive Agents -- Chapter 7. Plant Metabolites as New Leads to Anticancer Drug Discovery: Approaches and Challenges -- Chapter 8. Terpenes of Genus Salvia: Cytotoxicity and Antitumoral Effects -- Chapter 9. Essential Oil with Anticancer Activity: An Overview -- Chapter 10. Fungal Endophytes from Anticancer Plants as Producers of the Anti-tumour Agent L-Asparaginase: A Look at Diversity, Ubiquity and Enzyme Production -- Chapter 11. Xylooligosaccharides and their Anticancer Potential: An Update -- Chapter 12. Phytochemicals Targeting Endoplasmic Reticulum Stress to Inhibit Cancer Cell Proliferation -- Chapter 13. Remedy of Targeting Cancer andCcancer Stem Cells with Botanicals -- Chapter 14. Therapeutic Strategies of Natural Agents and its Components on Triple-Negative Breast Cancer -- Chapter 15. Endophytic Microbes as a Novel Source for Producing Anticancer Compounds as Multidrug Resistance Modulators. Chapter 16. Traditional Medicinal Plants and their Therapeutic Potential Against Major Cancer Types -- Chapter 17. Platelet Derived Growth Factor Receptor (PDGF-R) as the Target for Herbal Based Anticancer Agents -- Chapter 18. Plant Cell and Organ Culture as an Alternative for the Production of Anticancer Compounds -- Chapter 19. Plant Derived Extracts and Compounds: An Alternative Therapy Against Breast Cancer -- Chapter 20. Micropropagation and Conservation of Selected Endangered Anticancer Medicinal Plants from the Western Ghats of India -- Chapter 21. Biotechnological Approaches for the Propagation of Anticancer Plants and the Production of Vital Compounds -- Chapter 22. An Alternative Approach for Anticancer Compounds Production Through Plant Tissue Culture Techniques -- Chapter 23. Biotechnological Intervention Through Tissue Culture in Hedychium coronarium: A Potential Anticancer Plant. .

This volume provides summarized scientific evidence of the different classes of plant-derived phytocompounds, their sources, chemical structures, anticancer properties, mechanisms of action, methods of extraction, and their applications in cancer therapy. It also discusses endophyte-derived compounds as chemopreventives to treat various cancer types. In addition, it provides detailed information on the enhanced production of therapeutically valuable anticancer metabolites using biotechnological interventions such as plant cell and tissue culture approaches, including in vitro-, hairy root- and cell-suspension culture; and metabolic engineering of biosynthetic pathways. Anticancer Plants: Natural Products and Biotechnological Implements – Volume 2” explores the natural bioactive compounds isolated from plants as well as fungal endophytes, their chemistry, and preventive effects to reduce the risk of cancer. Moreover, it highlights the genomics/proteomics approaches and biotechnological implementations. Providing solutions to deal with the challenges involved in cancer therapy, the book benefits a wide range of readers including academics, students, and industrial experts working in the area of natural products, medicinal plant chemistry, pharmacology, and biotechnology.

ISBN: 9789811080647

Standard No.: 10.1007/978-981-10-8064-7doiSubjects--Topical Terms:

889548
Plant physiology.

LC Class. No.: QK710-899

Dewey Class. No.: 571.2

Anticancer Plants: Natural Products and Biotechnological Implements = Volume 2 /
LDR:05102nam a22003855i 4500 001 997451
003 DE-He213
005 20200705133610.0
007 cr nn 008mamaa
008 201225s2018 si | s |||| 0|eng d
020 $a 9789811080647 $9 978-981-10-8064-7
024 7 $a 10.1007/978-981-10-8064-7 $2 doi
035 $a 978-981-10-8064-7
050 4 $a QK710-899
072 7 $a PSTD $2 bicssc
072 7 $a SCI011000 $2 bisacsh
072 7 $a PST $2 thema
082 0 4 $a 571.2 $2 23
245 1 0 $a Anticancer Plants: Natural Products and Biotechnological Implements $h [electronic resource] : $b Volume 2 / $c edited by Mohd Sayeed Akhtar, Mallappa Kumara Swamy.
250 $a 1st ed. 2018.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a XV, 564 p. 139 illus., 21 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Fungal Endophytes as Novel Sources of Anticancer Compounds -- Chapter 2. Gastrointestinal Bezoar Stones: Current Knowledge and Future Pperspective on the Potential of Plant-derived Phytobezoar in Cancer Treatment -- Chapter 3. Potential of Natural Products for Prevention of Oral Cancer -- Chapter 4. Therapeutic Potential of Cardiac Glycosides Against Cancer -- Chapter 5. Conserving Biodiversity of a Potent Anticancer Plant, Catharanthus roseus Through In vitro Biotechnological Intercessions: Substantial Progress and Imminent Prospects -- Chapter 6. Medicinal Plants as a Potential Source of Chemopreventive Agents -- Chapter 7. Plant Metabolites as New Leads to Anticancer Drug Discovery: Approaches and Challenges -- Chapter 8. Terpenes of Genus Salvia: Cytotoxicity and Antitumoral Effects -- Chapter 9. Essential Oil with Anticancer Activity: An Overview -- Chapter 10. Fungal Endophytes from Anticancer Plants as Producers of the Anti-tumour Agent L-Asparaginase: A Look at Diversity, Ubiquity and Enzyme Production -- Chapter 11. Xylooligosaccharides and their Anticancer Potential: An Update -- Chapter 12. Phytochemicals Targeting Endoplasmic Reticulum Stress to Inhibit Cancer Cell Proliferation -- Chapter 13. Remedy of Targeting Cancer andCcancer Stem Cells with Botanicals -- Chapter 14. Therapeutic Strategies of Natural Agents and its Components on Triple-Negative Breast Cancer -- Chapter 15. Endophytic Microbes as a Novel Source for Producing Anticancer Compounds as Multidrug Resistance Modulators. Chapter 16. Traditional Medicinal Plants and their Therapeutic Potential Against Major Cancer Types -- Chapter 17. Platelet Derived Growth Factor Receptor (PDGF-R) as the Target for Herbal Based Anticancer Agents -- Chapter 18. Plant Cell and Organ Culture as an Alternative for the Production of Anticancer Compounds -- Chapter 19. Plant Derived Extracts and Compounds: An Alternative Therapy Against Breast Cancer -- Chapter 20. Micropropagation and Conservation of Selected Endangered Anticancer Medicinal Plants from the Western Ghats of India -- Chapter 21. Biotechnological Approaches for the Propagation of Anticancer Plants and the Production of Vital Compounds -- Chapter 22. An Alternative Approach for Anticancer Compounds Production Through Plant Tissue Culture Techniques -- Chapter 23. Biotechnological Intervention Through Tissue Culture in Hedychium coronarium: A Potential Anticancer Plant. .
520 $a This volume provides summarized scientific evidence of the different classes of plant-derived phytocompounds, their sources, chemical structures, anticancer properties, mechanisms of action, methods of extraction, and their applications in cancer therapy. It also discusses endophyte-derived compounds as chemopreventives to treat various cancer types. In addition, it provides detailed information on the enhanced production of therapeutically valuable anticancer metabolites using biotechnological interventions such as plant cell and tissue culture approaches, including in vitro-, hairy root- and cell-suspension culture; and metabolic engineering of biosynthetic pathways. Anticancer Plants: Natural Products and Biotechnological Implements – Volume 2” explores the natural bioactive compounds isolated from plants as well as fungal endophytes, their chemistry, and preventive effects to reduce the risk of cancer. Moreover, it highlights the genomics/proteomics approaches and biotechnological implementations. Providing solutions to deal with the challenges involved in cancer therapy, the book benefits a wide range of readers including academics, students, and industrial experts working in the area of natural products, medicinal plant chemistry, pharmacology, and biotechnology.
650 0 $a Plant physiology. $3 889548
650 0 $a Agriculture. $3 660421
650 0 $a Proteomics. $3 581930
650 0 $a Plant genetics. $3 743629
650 0 $a Cancer research. $3 1253664
650 1 4 $a Plant Physiology. $3 579850
650 2 4 $a Plant Genetics and Genomics. $3 1171617
650 2 4 $a Cancer Research. $3 668358
700 1 $a Akhtar, Mohd Sayeed. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1106468
700 1 $a Swamy, Mallappa Kumara. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1204278
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811080630
776 0 8 $i Printed edition: $z 9789811340529
856 4 0 $u https://doi.org/10.1007/978-981-10-8064-7
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)